Synovus Financial Corp lessened its position in CME Group Inc. (NASDAQ:CME) by 25.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 3,349 shares of the financial services provider’s stock after selling 1,165 shares during the period. Synovus Financial Corp’s holdings in CME Group were worth $420,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in CME. RMB Capital Management LLC lifted its holdings in CME Group by 3.1% during the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after acquiring an additional 3,501 shares during the period. Capital Advisors Inc. OK lifted its holdings in CME Group by 10.7% during the second quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after acquiring an additional 8,198 shares during the period. Thrivent Financial For Lutherans lifted its holdings in CME Group by 5.6% during the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock worth $1,485,000 after acquiring an additional 660 shares during the period. Commerce Bank lifted its holdings in CME Group by 3.8% during the second quarter. Commerce Bank now owns 560,899 shares of the financial services provider’s stock worth $70,247,000 after acquiring an additional 20,449 shares during the period. Finally, Principal Financial Group Inc. lifted its holdings in CME Group by 1.8% during the second quarter. Principal Financial Group Inc. now owns 488,477 shares of the financial services provider’s stock worth $61,176,000 after acquiring an additional 8,526 shares during the period. 82.64% of the stock is currently owned by institutional investors.
In related news, Chairman Terrence A. Duffy sold 21,815 shares of CME Group stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the sale, the chairman now directly owns 110,711 shares in the company, valued at approximately $13,715,985.79. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Bryan T. Durkin sold 9,200 shares of CME Group stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the sale, the president now owns 70,938 shares in the company, valued at $8,876,471.94. The disclosure for this sale can be found here. Insiders have sold a total of 48,244 shares of company stock worth $6,021,890 over the last quarter. 0.57% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: This piece was reported by BBNS and is the sole property of of BBNS. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://baseballnewssource.com/markets/cme-group-inc-cme-shares-sold-by-synovus-financial-corp/1600210.html.
A number of brokerages recently commented on CME. UBS AG reiterated a “buy” rating and set a $134.00 price target (down from $136.00) on shares of CME Group in a report on Monday, June 5th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $127.00 target price on shares of CME Group in a research note on Friday, July 14th. Finally, Citigroup Inc. assumed coverage on CME Group in a research note on Wednesday, July 12th. They issued a “buy” rating and a $140.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. CME Group has a consensus rating of “Buy” and an average price target of $133.22.
CME Group Inc. (CME) opened at 134.17 on Friday. The company’s 50-day moving average price is $126.73 and its 200 day moving average price is $122.14. The stock has a market capitalization of $45.61 billion, a PE ratio of 27.39 and a beta of 0.72. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $134.36.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the business earned $1.14 EPS. The company’s revenue was up 2.1% on a year-over-year basis. Equities analysts forecast that CME Group Inc. will post $4.82 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.97%. CME Group’s payout ratio is 53.99%.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with our FREE daily email newsletter.